Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




New Therapeutic Options in CML and What They Mean for Patients: An Expert Interview With Dr. Jorge C
Link ID 2753
Title New Therapeutic Options in CML and What They Mean for Patients: An Expert Interview With Dr. Jorge C
Url http://www.medscape.com/viewarticle/568343?src=rss
Description In this Expert Interview from ASH 2007, Dr. Jorge Cortes discusses new and follow-up data from clinical trials of drug therapies for CML.
Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Jan 29, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Prostate Cancer Genetics
  Dr. Eric Topol discusses a flood of new data on common genetic variants that could predict prostate cancer.
Category:   Articles > Hematology-Oncology


2. Cisplatin Should Not Replace Mitomycin in Treatment of Anal Canal Cancer
  Results from a phase 3 trial showed no improvement in disease-free survival with cisplatin, and a significantly worse colostomy rate. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Use of Tumor Markers Low in Testis Cancer
  The use of tumor markers in testis cancer is low and varies considerably in the United States, despite the role markers can play in providing information pertinent to diagnosis, risk stratification, response to therapy, and disease recurrence. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Present and Potential New Options for the Treatment of Myelodysplastic Syndrome-Related Thrombocytop
  In this Special Report, expert hematologists address the pros and cons of current therapies for myelodysplastic syndrome-related thrombocytopenia and detail promising investigational approaches. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. African American Women Less Likely to Undergo BRCA1/2 Genetic Testing
  In general, African American women are less likely than white women to pursue genetic testing for BRCA1/2, researchers report. However, African American women with a recent diagnosis of breast cancer are much more likely to do so, according to the article in the January 1st issue of the Journal of Clinical Oncology. Reuters Health Information
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS